Cargando…

Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach

Artemisinin resistance in Plasmodium falciparum threatens global efforts in the elimination or eradication of malaria. Several studies have associated mutations in the PfATP6 gene in conjunction with artemisinin resistance, but the underlying molecular mechanism of the resistance remains unexplored....

Descripción completa

Detalles Bibliográficos
Autores principales:	N., Nagasundaram, C., George Priya Doss, Chakraborty, Chiranjib, V., Karthick, D., Thirumal Kumar, V., Balaji, R., Siva, Lu, Aiping, Ge, Zhang, Zhu, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965867/ https://www.ncbi.nlm.nih.gov/pubmed/27471101 http://dx.doi.org/10.1038/srep30106

Ejemplares similares

Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname
por: Adhin, Malti R, et al.
Publicado: (2012)

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
por: Ashton, Trent D., et al.
Publicado: (2023)

Na(+) Regulation in the Malaria Parasite Plasmodiumfalciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
por: Spillman, Natalie J., et al.
Publicado: (2013)

Analysing the Effect of Mutation on Protein Function and Discovering Potential Inhibitors of CDK4: Molecular Modelling and Dynamics Studies
por: N, Nagasundaram, et al.
Publicado: (2015)

The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
por: Spillman, Natalie Jane, et al.
Publicado: (2015)

Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
por: Flannery, Erika L., et al.
Publicado: (2014)

Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins
por: Cardi, Delphine, et al.
Publicado: (2010)

Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus
por: Karthick, V., et al.
Publicado: (2016)

Questions over high frequency of mutant PfATP6 haplotypes in traveller isolates
por: Woodrow, Charles J, et al.
Publicado: (2012)

Metabolic responses in blood-stage malaria parasites associated with increased and decreased sensitivity to PfATP4 inhibitors
por: Tewari, Shivendra G., et al.
Publicado: (2023)

Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections
por: Pillai, Dylan R, et al.
Publicado: (2012)

A G358S mutation in the Plasmodium falciparum Na(+) pump PfATP4 confers clinically-relevant resistance to cipargamin
por: Qiu, Deyun, et al.
Publicado: (2022)

A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4
por: Gilson, Paul R., et al.
Publicado: (2019)

Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach
por: George Priya Doss, C, et al.
Publicado: (2013)

PfATP4 inhibitors in the Medicines for Malaria Venture Malaria Box and Pathogen Box block the schizont-to-ring transition by inhibiting egress rather than invasion
por: Barnes, Claudia B. G., et al.
Publicado: (2022)

Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors
por: C., George Priya Doss, et al.
Publicado: (2014)

Evolution- and Structure-Based Computational Strategy Reveals the Impact of Deleterious Missense Mutations on MODY 2 (Maturity-Onset Diabetes of the Young, Type 2)
por: George, Doss C. Priya, et al.
Publicado: (2014)

Structure-based drug design studies of the interactions of ent-kaurane diterpenes derived from Wedelia paludosa with the Plasmodium falciparum sarco/endoplasmic reticulum Ca(2+)-ATPase PfATP6
por: Guimarães, Daniel Silqueira Martins, et al.
Publicado: (2015)

Artemisinin Antimalarials: Preserving the “Magic Bullet”
por: Maude, Richard J, et al.
Publicado: (2010)

DNA binding by the antimalarial compound artemisinin
por: Slavkovic, Sladjana, et al.
Publicado: (2022)

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
por: O'Neill, Paul M., et al.
Publicado: (2017)

Anticancer Effect of AntiMalarial Artemisinin Compounds
por: Das, AK
Publicado: (2015)

Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)

Zika: How safe is India?
por: Doss, C. George Priya, et al.
Publicado: (2017)

Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian Amazon
por: Brasil, Larissa W, et al.
Publicado: (2012)

PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers
por: Eastman, Richard T., et al.
Publicado: (2016)

Antimalarial Activity of C-10 Substituted Triazolyl Artemisinin
por: Park, Gab-Man, et al.
Publicado: (2017)

Synthesis and Antimalarial Activity of Novel Dihydro-Artemisinin Derivatives
por: Liu, Yang, et al.
Publicado: (2011)

Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum
por: Sharma, Aabha I., et al.
Publicado: (2020)

A SAR and QSAR Study of New Artemisinin Compounds with Antimalarial Activity
por: Santos, Cleydson Breno R., et al.
Publicado: (2013)

Discovery of Small-Molecule Allosteric Inhibitors of PfATC as Antimalarials
por: Wang, Chao, et al.
Publicado: (2022)

Genetic validation of PfFKBP35 as an antimalarial drug target
por: Thommen, Basil T, et al.
Publicado: (2023)

Artemisinin Combination Therapy: A Good Antimalarial, but Is the Dose Right?
por: Garner, Paul
Publicado: (2013)

Stable Production of the Antimalarial Drug Artemisinin in the Moss Physcomitrella patens
por: Khairul Ikram, Nur Kusaira Binti, et al.
Publicado: (2017)

FABRICATION AND EVALUATION OF SMART NANOCRYSTALS OF ARTEMISININ FOR ANTIMALARIAL AND ANTIBACTERIAL EFFICACY.
por: Shah, Syed Muhammad Hassan, et al.
Publicado: (2016)

Split dosing of artemisinins does not improve antimalarial therapeutic efficacy
por: White, N. J., et al.
Publicado: (2017)

Direct Activation of TRPC3 Channels by the Antimalarial Agent Artemisinin
por: Urban, Nicole, et al.
Publicado: (2020)

Antimalarial and anticancer properties of artesunate and other artemisinins: current development
por: Khanal, Pitambar
Publicado: (2021)

Discovering antimalarials with a differential mode of action
por: Sanz, Laura, et al.
Publicado: (2014)

A plausible mechanism for the antimalarial activity of artemisinin: A computational approach
por: Shandilya, Ashutosh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nn49fe0151d8krh8aubkitbl7o